A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants
NCT05287360
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Rivoceranib
Sponsor
Elevar Therapeutics